T1	p 87 115	nonsmokers . Women who smoke
T2	p 426 446	users who smoke have
T3	p 559 576	cigarette smoking
T4	p 661 706	. Sixty healthy women , half of whom had been
T5	p 724 742	least the previous
T6	p 745 751	months
T7	p 767 773	in the
T8	p 812 823	smokers and
T9	p 874 882	nicotine
T10	p 946 956	nonsmokers
T11	p 1259 1266	users ,
T12	p 1512 1517	women
T13	p 1535 1557	among nonsmoking women
T14	i 6 24	Oral contraceptive
T15	i 125 152	oral contraceptives ( OCs )
T16	i 423 431	OC users
T17	i 585 593	nicotine
T18	i 615 617	OC
T19	i 713 716	OCs
T20	i 868 912	12-hr nicotine deprivation or administration
T21	i 916 930	nicotine gum .
T22	i 1038 1060	videotaped speech task
T23	i 1185 1208	nicotine administration
T24	i 1394 1402	nicotine
T25	i 1435 1443	nicotine
T26	i 1485 1497	lipid stress
T27	o 48 83	increased cardiovascular reactivity
T28	o 182 204	risk of cardiovascular
T29	o 278 320	Cardiovascular reactivity to psychological
T30	o 387 393	number
T31	o 615 617	OC
T32	o 625 662	cardiovascular and lipid reactivity .
T33	o 959 1007	Heart rate , blood pressure , and lipid measures
T34	o 1167 1181	smoking status
T35	o 1212 1239	cardiovascular reactivity .
T36	o 1296 1364	greater heart rate and diastolic blood pressure reactivity to stress
T37	o 1467 1508	cardiovascular or lipid stress reactivity
T38	o 1577 1613	greater cardiovascular reactivity to